Abstract
The genus Broussonetia of the Moraceae (mulberry family) is of both ethnomedical and industrial interest. Of the approximately 30 species in this genus, only three have been subjected to previous phytochemical investigation, namely, B. kazinoki, B. papyrifera, and B. zeylanica. From over 100 compounds isolated from these species, the major secondary metabolites reported thus far are alkaloids of the pyrrolidine type and several types of flavonoids. Some of these compounds have exhibited various biological activities, such antioxidative, aromatase inhibitory, cytotoxic, glycosidase inhibitory, and platelet aggregation inhibitory effects. The biologically active constituents of the species in the genus Broussonetia are discussed in detail.
Original language | English |
---|---|
Title of host publication | Studies in Natural Products Chemistry |
Publisher | Elsevier |
Pages | 3-33 |
Number of pages | 31 |
Edition | PART I |
DOIs | |
Publication status | Published - 2003 |
Externally published | Yes |
Publication series
Name | Studies in Natural Products Chemistry |
---|---|
Number | PART I |
Volume | 28 |
ISSN (Print) | 1572-5995 |
Bibliographical note
Funding Information:The laboratory work on potential cancer chemopreventive agents carried out at the University of Illinois at Chicago was supported by program project P01 CA48112 (Principal Investigator, John M. Pezzuto, Ph.D.), funded by the National Cancer Institute, NIH, Bethesda, Maryland, U.S.A.
Copyright:
Copyright 2019 Elsevier B.V., All rights reserved.
ASJC Scopus subject areas
- Drug Discovery
- Organic Chemistry